Purdue Pharma has agreed to pay $270 million to settle a lawsuit brought by Oklahoma that claimed it used deceptive marketing tactics to increase sales of opioid drugs, contributing to the state’s
Care standards and ethics in the NHS are once again under scrutiny after a report found that overprescription of opiates at Gosport War Memorial Hospital shortened hundreds of lives.
Nine months after filing their TROP2-directed antibody-drug conjugate Dato-DXd for a lung cancer indication with the FDA, Daiichi Sankyo and AstraZeneca have pulled the submission.
Investigator sites are essential for successful execution of clinical trials – ensuring studies are conducted ethically, safely, and in compliance with regulatory standards.